The CVC market is projected to grow from USD 2,861.0 million in 2024 to USD 5,436.8 million by 2034 at a CAGR of 6.6%.
Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...
and 2 mg to clear clots in central venous catheters pending the results of a study to determine the effectiveness of smaller doses.
Peripherally inserted central catheters (PICCs) are frequently used to obtain central venous access for patients in acute care, home care and skilled nursing care. PICCs are a reliable alternative ...
Central Venous Catheters All catheters consists of high flexible thin-walled polyurethane which ensures very high flow rates. It is anti-thrombogen and biocompatible. At body temperature it gets ...
“As the market leader in both Central Venous Catheters (CVCs) 1 and Arterials 2, we are pleased to offer Vizient provider-customers one of the broadest portfolios of vascular access products ...